摘要
目的分析血浆硬化蛋白(sclerostin)水平与膝骨关节炎(KOA)严重程度的相关性。方法选取KOA女性患者和健康女性各95例,ELISA检测血浆中sclerostin、CTX-II和aggrecan降解片段AGG1及AGG2的浓度。根据Kellgrene&Lawrence(KL)分级对95例KOA患者进行X线分级,并进行相关分析。结果 KOA患者血浆sclerostin浓度明显低于对照组(P<0.001)。血浆sclerostin浓度与KL分级负相关(r=-0.828,P<0.001),与血浆CTX-II(r=-0.917,P<0.001)、AGG1(r=-0.658,P<0.001)、AGG2(r=-0.583,P<0.001)负相关。结论 KOA患者的血浆sclerostin浓度与软骨退变程度相关,有助于在临床上监测病情进展以及评价病情的严重性。
Objective To investigated the relationship between plasma sclerostin (SOST) and knee osteoarthritis (KOA). Methods A total of 95 patients with KOA and 95 healthy people were involved. Plasma sclerostin, CTX-II, AGG1 and AGG2 levels were measured by ELISA. The 95 patients were divided based on Kellgren-Law- fence classification. The correlation between plasma SOST level and KL classification, CTX-II, AGGI and AGG2 were analyzed. Results Plasma SOST level in KOA was significantly lower than that in control gronp (P 〈 0.001 ). SOST level was negatively correlated with KL grade (r = -0.828, P 〈 0.001), also with CTX-II (r = -0.917, P 〈 0.001), AGG1 (r = -0.658, P 〈 0.001) and AGG2 (r = -0.583, P 〈 0.001). Conclusions SOST level in KOA patients is related to the degree of cartilage degeneration. Thus, it helps to monitor the progress and evaluate the severity of the KOA.
出处
《实用医学杂志》
CAS
北大核心
2018年第3期443-445,共3页
The Journal of Practical Medicine